141 related articles for article (PubMed ID: 24013743)
1. Alzheimer's and prion diseases: PDK1 at the crossroads.
Checler F
Nat Med; 2013 Sep; 19(9):1088-90. PubMed ID: 24013743
[TBL] [Abstract][Full Text] [Related]
2. PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases.
Pietri M; Dakowski C; Hannaoui S; Alleaume-Butaux A; Hernandez-Rapp J; Ragagnin A; Mouillet-Richard S; Haik S; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
Nat Med; 2013 Sep; 19(9):1124-31. PubMed ID: 23955714
[TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative disease: PDK1--a common therapeutic target for AD and prion disease?
Wood H
Nat Rev Neurol; 2013 Oct; 9(10):543. PubMed ID: 24018477
[No Abstract] [Full Text] [Related]
4. Neurodegenerative diseases: New kinase targets for Alzheimer's disease.
Flight MH
Nat Rev Drug Discov; 2013 Oct; 12(10):739. PubMed ID: 24080693
[No Abstract] [Full Text] [Related]
5. [From prion diseases to Alzheimer's disease: a common therapeutic target, PDK1].
Pietri M; Alleaume-Butaux A; Launay JM; Kellermann O; Schneider B
Med Sci (Paris); 2014 Feb; 30(2):139-41. PubMed ID: 24572109
[No Abstract] [Full Text] [Related]
6. Production of seedable Amyloid-β peptides in model of prion diseases upon PrP
Ezpeleta J; Baudouin V; Arellano-Anaya ZE; Boudet-Devaud F; Pietri M; Baudry A; Haeberlé AM; Bailly Y; Kellermann O; Launay JM; Schneider B
Nat Commun; 2019 Aug; 10(1):3442. PubMed ID: 31371707
[TBL] [Abstract][Full Text] [Related]
7. α-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins.
Vincent B; Checler F
Curr Alzheimer Res; 2012 Feb; 9(2):140-56. PubMed ID: 21605031
[TBL] [Abstract][Full Text] [Related]
8. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
9. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
10. Protective role of cellular prion protein against TNFα-mediated inflammation through TACE α-secretase.
Ezpeleta J; Boudet-Devaud F; Pietri M; Baudry A; Baudouin V; Alleaume-Butaux A; Dagoneau N; Kellermann O; Launay JM; Schneider B
Sci Rep; 2017 Aug; 7(1):7671. PubMed ID: 28794434
[TBL] [Abstract][Full Text] [Related]
11. Carnosic acid suppresses the production of amyloid-β 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells.
Meng P; Yoshida H; Matsumiya T; Imaizumi T; Tanji K; Xing F; Hayakari R; Dempoya J; Tatsuta T; Aizawa-Yashiro T; Mimura J; Kosaka K; Itoh K; Satoh K
Neurosci Res; 2013 Feb; 75(2):94-102. PubMed ID: 23257508
[TBL] [Abstract][Full Text] [Related]
12. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
13. Prion and TNFα: TAC(E)it agreement between the prion protein and cell signaling.
Stella R; Massimino ML; Sorgato MC; Bertoli A
Cell Cycle; 2010 Dec; 9(23):4616-21. PubMed ID: 21099358
[TBL] [Abstract][Full Text] [Related]
14. The close link between retinoid signalling and the α-secretase ADAM10 and its potential for treating Alzheimer's disease (commentary on Jarvis et al.).
Fahrenholz F
Eur J Neurosci; 2010 Oct; 32(8):1245. PubMed ID: 20973156
[No Abstract] [Full Text] [Related]
15. Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo.
Kim ML; Zhang B; Mills IP; Milla ME; Brunden KR; Lee VM
J Neurosci; 2008 Nov; 28(46):12052-61. PubMed ID: 19005070
[TBL] [Abstract][Full Text] [Related]
16. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases.
Jacobsen KT; Adlerz L; Multhaup G; Iverfeldt K
J Biol Chem; 2010 Apr; 285(14):10223-31. PubMed ID: 20139073
[TBL] [Abstract][Full Text] [Related]
18. Games played by rogue proteins in prion disorders and Alzheimer's disease.
Aguzzi A; Haass C
Science; 2003 Oct; 302(5646):814-8. PubMed ID: 14593165
[TBL] [Abstract][Full Text] [Related]
19. Interactions between APP secretases and inflammatory mediators.
Sastre M; Walter J; Gentleman SM
J Neuroinflammation; 2008 Jun; 5():25. PubMed ID: 18564425
[TBL] [Abstract][Full Text] [Related]
20. Isoform-specific contribution of protein kinase C to prion processing.
Alfa Cissé M; Louis K; Braun U; Mari B; Leitges M; Slack BE; Fisher A; Auberger P; Checler F; Vincent B
Mol Cell Neurosci; 2008 Nov; 39(3):400-10. PubMed ID: 18722532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
